← Eichor
Study identifier: NCT04228978 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Condition: Peripheral Artery Disease · Overweight or Obesity  ·  Sponsor: Northwestern University

PhaseNA
Planned participants212
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk distance at 12 month follow-up than walking exercise alone in people with PAD and BMI\>25 kg/m2. The intervention uses a Group Mediated Cognitive Behavioral framework, connective mobile technology, remote monitoring by a coach, and a calorie restricted Dietary Approaches to Stop Hypertension (DASH)-derived Optimal Macronutrient Intake Trial for Heart Health (OMNIHeart) diet. 212 participants with PAD and BMI \> 25 kg/m2 will be randomized to one of two groups: weight loss + exercise (WL+EX) vs. exercise alone (EX). Participants will be randomized at Northwestern, Tulane University, and University of Minnesota. Our primary outcome is change in six-minute walk distance at 12-month follow-up. Secondary outcomes are change in 6-minute walk distance at 6-month follow-up and change in exercise adherence, physical activity, patient-reported walking ability (measured by the Walking Impairment Questionnaire (WIQ) distance score), and mobility (measured by the Patient-Reported Outcomes Measurement Information System \[PROMIS\] mobility questionnaire) at 12-month follow-up. Tertiary outcomes are perceived exertional effort (measured by the Borg scale at the end of the 6-minute walk at 12-month follow-up), and diet quality. Exploratory outcomes consist of change in the short physical performan…

This description comes directly from the study's public registry record.

Talk to the study team

Mary M McDermott, MD  ·  312-503-6419  ·  mdm608@northwestern.edu

Kathryn J Domanchuk, BS  ·  312-503-6438  ·  k-domanchuk@northwestern.edu

Always discuss trial participation with your own doctor first.

Locations (7)

Northwestern UniversityChicago, Illinois, United StatesRecruiting
University of ChicagoChicago, Illinois, United StatesRecruiting
Tulane UniversityNew Orleans, Louisiana, United StatesActive Not Recruiting
Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting
Henry Ford HealthDetroit, Michigan, United StatesRecruiting
University of MinnesotaMinneapolis, Minnesota, United StatesRecruiting
Ohio State UniversityColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04228978